Media contact: Stéphanie Bardon – communication@genethon.fr – 01.69.47.12.78
April 29, 2024
GenoTher, biocluster in the field of gene therapy is officially launched
April 23, 2024
First Clinical Trial Results of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy presented at International Myology 2024 Congress
April 22, 2024
Genethon will introduce its latest advances in gene therapy research in multiple presentations at the International Myology 2024 Congress
February 28, 2024
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Diseases
November 17, 2023
Clinical results of the gene therapy trial in myotubular myopathy : efficacy on respiratory and motor functions in this extremely severe disease, challenges ahead
October 24, 2023
The Latest Research of 14 Généthon Scientists to be Featured at the European Society of Gene & Cell Therapy’s 30th Annual Congress, Oct. 24-27, 2023, in Brussels, Belgium
August 17, 2023
First results of Crigler-Najjar clinical trial published in New England Journal of Medicine
July 12, 2023
Genethon and Thales collaborate on artificial intelligence to improve bioproduction efficiency
May 12, 2023
Genethon’s R&D to be Featured in Multiple Presentations at American Society of Gene & Cell Therapy Annual Meeting May 16-20, 2023, in Los Angeles, CA
ILTOO Pharma and the MIROCALS Consortium announce the signing of Licence Agreement for the development of low dose interleukin-2 as a potential treatment for Amyotrophic Lateral Sclerosis (ALS)
April 27, 2023
Crigler-Najjar syndrome: Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy for patients with anti-AAV antibodies
March 6, 2023
Crigler-Najjar Syndrome: Genethon obtains PRIME priority drug status from the EMA for its gene therapy
January 10, 2023
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
October 11, 2022
Genethon’s Latest Research, Including Advances in Gene Editing and AAV Delivery Vectors for Gene Therapy, to be Featured at European Society for Gene and Cell Therapy, Oct. 11-14, 2022
The gene therapy pioneering organization’s scientists will make multiple presentations on research aimed at curing rare diseases.
(read more)